Gonadal Steroids in the Treatment of Mood Disorders
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
UNLABELLED: Increased interest in the complex interplay between gonadal steroids and neurotransmitter systems involved in mood has led investigators to question the role of gonadal steroids in the treatment of affective disorders, especially in women. OBJECTIVES: The purpose of this article is to provide a rationale for using gonadal hormones in the treatment of depression in women. METHODS: The literature is reviewed regarding 1) sex-specific phenomenologic and epidemiologic differences in the manifestation of psychiatric illness, 2) sex-specific differences in the therapeutic and adverse effects of psychotropic medications, 3) the complex interplay between gonadal steroids and neurotransmitter systems implicated in psychiatric disorders, and 4) the growing literature regarding the use of estrogen and progesterone in the treatment of mood disorders in women and androgens in the treatment of depression and sexual dysfunction in both men and women. RESULTS: Findings from pharmacologic trials of estrogen and androgens are encouraging, albeit mixed, in the treatment of mood disorders and decreased libido in women, respectively. Controlled studies have failed to confirm early open-label reports of the effectiveness of progesterone in the treatment of premenstrual syndrome. CONCLUSIONS: Pending replication, estrogen may become an important pharmacologic agent in the treatment of postnatal and perimenopausal depression, whereas androgens have been shown to improve libido in postmenopausal women and hypogonadal men. Progesterone cannot be recommended as a treatment for premenstrual syndrome or postnatal depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of Postnatal Depression: Development of the 10-item Edinburgh Postnatal Depression Scale
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.6.782 · Cited by 14,183
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300 · cited 1×
“Although the difference did not achieve statistical significance secondary to the small sample size, the findings suggest that women with PPD do respond to treatment with TCAs at approximately the same rate as that reported by the National Institute of Mental Health Treatment of Depression Collaborative Research Proje…”
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“Allopregnanolone, the 5a-reduced metabolite of progesterone, is a potent barbiturate-like ligand of the GABA receptor–chloride ion channel complex, which has potent sedative and hypnotic effects (95).”
Kessler, R. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90026-g · Cited by 2,207 · cited 1×
“Interestingly, several community-based surveys of major depression in both men and women have found that women are three to four times more likely than men to develop major depression during midlife (45–55 years) compared with the 2:1 female to male ratio that exists from puberty to midlife (5, 19).”
Childhood and adolescent depression: a review of the past 10 years, Part I
BIRMAHER, B., RYAN, N. D., WILLIAMSON, D. E., BRENT, D. A., KAUFMAN, J., DAHL, R. E., PEREL, J., & NELSON, B. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00011 · Cited by 2,076
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Epidemiology of Puerperal Psychoses
Kendell, R. E., Chalmers, J. C., & Platz, C. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.5.662 · Cited by 1,119 · cited 2×
“A similar 3-month postpartum risk period has been found in outpatient populations for both depressive and anxiety syndromes (26, 28, 132).”
A Prospective Study of Emotional Disorders in Childbearing Women
Kumar, R., & Robson, K. M. (1984) · British Journal of Psychiatry · doi:10.1192/bjp.144.1.35 · Cited by 980 · cited 2×
“With respect to prevalence, Kumar and Robson (29) found a prevalence rate of depression (RDC minor or major) of 14% in the first 3 months postpartum compared with 4.2% during the 3 months before pregnancy.”
InfluentialEffects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841 · cited 1×
“Similarly, dehydroepiandrosterone was found in a recent double-blind, placebo-controlled trial to have mood-elevating effects in older men and women (173).”
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
Cited by
NELSON, E. E., LEIBENLUFT, E., McCLURE, E. B., & PINE, D. S. (2005) · Psychological Medicine · doi:10.1017/s0033291704003915 · Cited by 1,075
In vivo effects of a GPR30 antagonist
Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., Bologa, C. G., Leitao, A., Brailoiu, E., Deliu, E., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.168 · Cited by 532
Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression
Galea, L. A. M., Wide, J. K., & Barr, A. M. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00170-x · Cited by 284
Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test
Estrada-Camarena, E., Fernández-Guasti, A., & López-Rubalcava, C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300097 · Cited by 211
Changes in sleep quality, but not hormones predict time to postpartum depression recurrence
Okun, M. L., Luther, J., Prather, A. A., Perel, J. M., Wisniewski, S., & Wisner, K. L. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.015 · Cited by 154
Self-citation
Metadata
- Authors
- Epperson, C. N., Wisner, K. L., & Yamamoto, B.
- Venue
- Psychosomatic Medicine
- Published
- 1999-09
- Volume
- 61
- Issue
- 5
- Pages
- 676-697
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2056918492
- Cited by
- 120
- References
- 24
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gonadal Steroids in the Treatment of Mood Disorders. https://app.cochat.ai/papers/10.1097/00006842-199909000-00010
- The paper
- Epperson, C. N., Wisner, K. L., & Yamamoto, B. (1999). Gonadal Steroids in the Treatment of Mood Disorders. Psychosomatic Medicine. https://doi.org/10.1097/00006842-199909000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.